Donald S. Levy

856 citations

25 papers · 274 indexed · h-index 9

Co-authors: John Anderson Timothy Craig William R. Lumry Paul K. Keith Juthaporn Cowan Marc A. Riedl Ingo Pragst Michael Manning
Topics: Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers)Vitamin K Research Studies (6 papers)Autoimmune Bullous Skin Diseases (5 papers)
Cited by: Genetics Rheumatology Hematology
Journals: Journal of Allergy and Clinical Immunology The Journal of Pediatrics American Journal of Ophthalmology
Partner nations: United States Germany United Kingdom

In The Last Decade

Donald S. Levy

22 papers receiving 263 citations

Peers

Countries citing papers authored by Donald S. Levy

Since Specialization

Citations

This map shows the geographic impact of Donald S. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald S. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald S. Levy more than expected).

Fields of papers citing papers by Donald S. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald S. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald S. Levy. The network helps show where Donald S. Levy may publish in the future.

Co-authorship network of co-authors of Donald S. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Donald S. Levy. A scholar is included among the top collaborators of Donald S. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald S. Levy. Donald S. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Efficacy Of Garadacimab For Hereditary Angioedema In Patients With Or Without Prior Exposure In A Phase 3 Open-Label Extension Study 2025 ·Journal of Allergy and Clinical Immunology ·John Anderson,Timothy Craig,Hilary Longhurst,Donald S. Levy,Jonathan A. Bernstein,(unknown),John‐Philip Lawo,H. Shekar Shetty,(unknown)	0
2	Quality of life and burden of disease in patients with hereditary angioedema and their caregivers 2025 ·Allergy and Asthma Proceedings ·Donald S. Levy,Fumihiko Nagase,Antoinette Cheung,(unknown),Michael Manning	1
3	Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study 2024 ·The Lancet Haematology ·Timothy Craig,Donald S. Levy,Avner Reshef,William R. Lumry,Inmaculada Martinez‐Saguer,Joshua Jacobs,William H. Yang,Bruce Ritchie,Emel Aygören‐Pürsün,Paul K. Keith,Paula J. Busse,Henrike Feuersenger,(unknown),Iris Jacobs,Ingo Pragst,Markus Magerl	8
4	Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes 2024 ·Journal of Allergy and Clinical Immunology ·Mark Davis‐Lorton,Donald S. Levy,Douglas Johnston,(unknown),(unknown),(unknown),(unknown),William R. Lumry	2
5	An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy 2023 ·Allergy and Asthma Proceedings ·William R. Lumry,Jonathan A. Bernstein,(unknown),Donald S. Levy,Douglas H. Jones,(unknown),(unknown),Raffi Tachdjian	4
6	Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy 2021 ·Allergy Asthma and Clinical Immunology ·John Anderson,Donald S. Levy,William R. Lumry,Patricia Koochaki,(unknown),(unknown)	14
7	Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study 2021 ·Orphanet Journal of Rare Diseases ·William R. Lumry,Bruce L. Zuraw,Marco Cicardi,Timothy Craig,John Anderson,Aleena Banerji,Jonathan A. Bernstein,Teresa Caballero,Henriette Farkas,Richard Gower,Paul K. Keith,Donald S. Levy,H. Henry Li,Markus Magerl,Michael Manning,Marc A. Riedl,John‐Philip Lawo,(unknown),Thomas Machnig,Hilary Longhurst,(unknown)	24
8	Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study 2021 ·Orphanet Journal of Rare Diseases ·William R. Lumry,Bruce L. Zuraw,Marco Cicardi,Timothy Craig,John Anderson,Aleena Banerji,Jonathan A. Bernstein,Teresa Caballero,Henriette Farkas,Richard Gower,Paul K. Keith,Donald S. Levy,H. Henry Li,Markus Magerl,Michael Manning,Marc A. Riedl,John‐Philip Lawo,(unknown),Thomas Machnig,Hilary Longhurst,(unknown)	0
9	Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema 2020 ·Pediatric Allergy Immunology and Pulmonology ·Donald S. Levy,Teresa Caballero,Iftikhar Hussaın,Avner Reshef,John Anderson,James Baker,Lawrence B. Schwartz,Marco Cicardi,(unknown),Henrike Feuersenger,Ingo Pragst,Michael Manning	16
10	Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial 2020 ·Allergy Asthma and Clinical Immunology ·Donald S. Levy,Henriette Farkas,Marc A. Riedl,Florence Ida Hsu,(unknown),Marco Cicardi,Henrike Feuersenger,Ingo Pragst,Avner Reshef	14
11	Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy 2020 ·Journal of Infusion Nursing ·William R. Lumry,(unknown),Laurel Omert,Donald S. Levy	3
12	Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review 2020 ·Allergy Asthma and Clinical Immunology ·Donald S. Levy,Timothy Craig,Paul K. Keith,Girishanthy Krishnarajah,Rachel Beckerman,(unknown)	20
13	Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study 2019 ·Allergy Asthma and Clinical Immunology ·H. Henry Li,Bruce L. Zuraw,Hilary Longhurst,Marco Cicardi,Konrad Bork,James Baker,William R. Lumry,Jonathan A. Bernstein,Michael Manning,Donald S. Levy,Marc A. Riedl,Henrike Feuersenger,(unknown),Ingo Pragst,Thomas Machnig,Timothy Craig,(unknown)	9
14	Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema 2018 ·The Journal of Allergy and Clinical Immunology In Practice ·William R. Lumry,Timothy Craig,Bruce L. Zuraw,Hilary Longhurst,James Baker,H. Henry Li,Jonathan A. Bernstein,John Anderson,Marc A. Riedl,Michael Manning,Paul K. Keith,Donald S. Levy,Teresa Caballero,Aleena Banerji,Richard Gower,Henriette Farkas,John‐Philip Lawo,Ingo Pragst,Thomas Machnig,Douglas J. Watson	67
15	A case of localized adrenergic urticaria mimicking an allergic reaction to a sweat chloride test 2009 ·Pediatric Pulmonology ·(unknown),Vicky A. LeGrys,David Cooper,Donald S. Levy,(unknown),Christina D. Schwindt	4
16	Lifetime risk of developing coronary heart disease (multiple letters) [1] 1999 ·Gracious R. Ross,(unknown),Donald M. Lloyd‐Jones,Donald S. Levy,(unknown),(unknown),Silvia Ulrich,Aroon D. Hingorani,(unknown),Patrick Vallance	3
17	Herpesvirus Antibody Levels in the Etiologic Diagnosis of the Acute Retinal Necrosis Syndrome 1992 ·American Journal of Ophthalmology ·Jay S. Pepose,Brian Flowers,John A. Stewart,Charles Grose,Donald S. Levy,William W. Culbertson,Allan E. Kreiger	35
18	OKT4 epitope deficiency as a cause of reduced “helper” T cells in children at risk for human immunodeficiency virus infection 1988 ·The Journal of Pediatrics ·Donald S. Levy,Joseph A. Church,Warren Richards	4
19	193 OKT-4 Epitope deficiency as a cause of reduced “helper” T-cells in patients (Pts) at risk for human immunodeficiency virus (HIV) infection 1988 ·Journal of Allergy and Clinical Immunology ·Joseph A. Church,Donald S. Levy	1
20	The Effect of Topical Hydrocortisone Acetate Ointment at the Site of Intracutaneous Tuberculin Reaction 1959 ·PubMed ·Donald S. Levy,William F. Russell	1

About Donald S. Levy

Donald S. Levy is a scholar working on Genetics, Hematology and Nutrition and Dietetics, having authored 25 papers that have together received 274 indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Vitamin K Research Studies (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). The work is most often cited by research in Genetics (182 citations), Rheumatology (85 citations) and Hematology (55 citations). Donald S. Levy has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include John Anderson, Timothy Craig, William R. Lumry, Paul K. Keith, Juthaporn Cowan, Marc A. Riedl, Ingo Pragst, Michael Manning, Henriette Farkas and Antônio Condino‐Neto. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Pediatrics and American Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact